Commentary on "USP13 promotes hepatic stellate cells activation and aggravates liver fibrosis through deubiquitinating SMAD3"
- PMID: 40954426
- DOI: 10.1007/s12072-025-10911-6
Commentary on "USP13 promotes hepatic stellate cells activation and aggravates liver fibrosis through deubiquitinating SMAD3"
Conflict of interest statement
Declarations. Conflict of interest: The authors have no conflicts to report. Ethical approval: There are no ethical issues.
Comment on
-
USP13 promotes hepatic stellate cells activation and aggravates liver fibrosis through deubiquitinating SMAD3.Hepatol Int. 2025 Jul 28. doi: 10.1007/s12072-025-10880-w. Online ahead of print. Hepatol Int. 2025. PMID: 40719972
References
-
- Wang A, Dong H, Cui Y, et al. USP13 promotes hepatic stellate cells activation and aggravates liver fibrosis through deubiquitinating SMAD3. Hepatol Int. 2025. https://doi.org/10.1007/s12072-025-10880-w - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
